Inovio’s upside hinges on INO-3107 for HPV-6/11 RRP with FDA PDUFA Oct 2026, regulatory risk, tight cash, and cheap EV. Check ...

Tens of millions of Americans turn to cannabis products every week to try to ease their pain, calm their anxiety, get more ...

Humans ask what things mean. Animals move on. That difference explains both our brilliance and much of our psychological ...

Emerging research suggests women’s cardiovascular systems may respond more strongly to physical activity than men’s, raising ...

Neuralink has officially begun human trials of its latest brain implant. This video explains what is being tested, who the trials are designed to help, and why this phase matters more than any ...

Success rates in phase II and phase III clinical trials are recognized as two of the most powerful drivers of overall efficiency in drug development (Nat. Rev. Drug Disc. 23, 656–657; 2024). With the ...

Last year, we ran a randomized controlled trial working with frontline workers in the homelessness sector, which aimed to increase their well-being. The project, which began at the What Works Center ...

Mr. Orszag is the chairman and chief executive of Lazard. He was a director of the Office of Management and Budget in the Obama administration. The health care reform debate has become — already was — ...

With notable therapies from Biogen, Sarepta and MacroGenics failing to show efficacy in pivotal or confirmatory trials, experts question the use of biomarker evidence for approval while one former ...

I wrote in the summer about changing the disease-modifying therapy (DMT) for my multiple sclerosis (MS). I’ve familiarized myself with the available DMTs, and I plan to ask my neurologist for her ...